Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 8/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14078005 | 0.93 | — | — | |
| SCHEMBL12763965 | 0.88 | MEN1 (0.34) | — | |
| SCHEMBL12764001 | 0.86 | — | — | |
| SCHEMBL12763962 | 0.86 | MEN1 (0.35) | — | |
| SCHEMBL12763963 | 0.85 | — | — | |
| SCHEMBL4085633 | 0.82 | HDAC6 (0.34) | ACHEBCHE | |
| SCHEMBL14078004 | 0.82 | KDM4E (0.31) | — | |
| SCHEMBL12763960 | 0.80 | ALDH1A1 (0.32) | ACHEBCHE | |
| SCHEMBL14078007 | 0.79 | MEN1 (0.32) | — | |
| SCHEMBL12763955 | 0.78 | TGM2 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9228225-B2 | Xanthene dyes | BIOSEARCH TECHNOLOGIES, INC. (US) | 2016-01-05 | — | — | US | disclosed |
| US-20110054165-A1 | XANTHENE DYES | BIOSEARCH TECHNOLOGIES, INC. (US) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054165-A1 | XANTHENE DYES | ANXA5, ANTXR2, XPOT | ACHE 27/4885BCHE 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.